Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28)

Virology Journal

Volumn 2, Issue , 2005, Pages

  Mavoungou, Donatien ^a   Poaty Mavoungou, Virginie ^a,b   Akoume, Marie Yvonne ^c   Ongali, Brice ^c   Mavoungou, Elie ^a,b  

^a Ctr Rech Sur Les Pathologies H   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DRUG ANALOG; IMMUNOR; PRASTERONE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; CELL FUSION; CELL PROTECTION; COCULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; MEDICAL ASSESSMENT; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION;

CELL FUSION; CELL LINE; DEHYDROEPIANDROSTERONE; DEXAMETHASONE; GENE PRODUCTS, ENV; HIV FUSION INHIBITORS; HIV-1; HUMANS; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 15544366774     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-2-9     Document Type: Article

References (34)

1. McKnight A, Dittmar MT, Miniz-Pereira J, et al.: A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as co-receptors with CD4. J Virol 1998, 72:4065-71.
2. Paxton WA, Liu R, Kang S, et al.: Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. Virology 1998, 244:66-73.
3. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD: In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus co-receptors: CXCR4, CCR3, and CCR5. J Virol 1998, 72:5035-45.
4. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-33.
5. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-15.
6. Oberlin E, Amara A, Bachelerie F, et al.: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996, 382:833-35.
7. Gallaher WR: Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 1997, 50:327-28.
8. Larsen C, Ellens H, Bentz J: Membrane fusion induced by HIV env glycoprotein. Adv Membr Fluid 1992, 6:143-66.
9. Kowalski M, Bergeron L, Dorfman T, Haseltine W, Sodroski J: Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelop glycoprotein. J Virol 1991, 65:281-291.
10. Mobley PW, Curtain CC, Kirkpatrick A, Rostamkhani M, Waring AJ, Gordon LM: The amino-terminal peptide of HIV-1 glycoprotein 41 lyses human erythrocytes and CD4+ lymphocytes. Biochem Biophys Acta 1992, 1139:251-56.
11. Moore JP, Bradford AJ, Weiss R, Sattentau QJ: The HIV-cell fusion reaction. In Viral Fusion Mechanism Edited by: Benz J. CRC Press, Boca Raton, Florida; 1993:223-289.
12. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 1996, 272:872-77.
13. Dragic T, Litwin V, Allaway GP: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-73.
14. Diallo K, Loemba H, Oliveira M, Mavoungou DD, Wainberg MA: Inhibition of human immunodeficiency virus type-1 (HIV-1) replication by immunor (IM28), a new analog of dehydroepiandrosterone. Nucleosides Nucleotides Nucleic Acids 2000, 19:2019-2024.
15. Reil H, Hoxter M, Moosmayer D, Pauli G, Hauser H: CD4 expressing human 293 cells as a tool for studies in HIV-1 replication: the efficiency of translational frameshifting is not altered by HIV-1 infection. Virology 1994, 205:371-75.
16. Kruger U, Pfeiffer T, Bosch V: Generation of lymphocyte cell lines co expressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis. AIDS Res Hum Retroviruses 1996, 12:783-92.
17. Volsky B, Sakai K, Reddy MM, Volsky DJ: A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation. Virology 1992, 186:303-308.
18. Mavoungou E, Georges-Courbot MC, Poaty-Mavoungou V, et al.: HIV and SIV envelope glycoproteins induce phospholipase A2 activation in human and macaque lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:1-9.
19. Mavoungou E, Poaty-Mavoungou V: CD4/GP120mac251 interaction induces phospholipase A2 (PLA2) activation in cynomolgus monkey lymphocytes. J Med Primatol 1998, 27:193-201.
20. Dennis EA, Rhee SG, Billah MM, Hannun YA: Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J 1991, 5:2068-77.
21. Kim D, Clapham DE: Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. Science 1989, 244:1174-76.
22. Bonventre JV: Phospholipase A2 and signal transduction. J Am Soc Nephrol 1992, 3:128-50.
23. Gualde N, Atluru D, Goodwin JS: Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J Immunol 1985, 134:1125-29.
24. Aguilar JJ, Anel A, Torres JM, Semmel M, Uriel J: Changes in lipid composition of human peripheral blood lymphocytes infected by HIV. AIDS Res Hum Retroviruses 1991, 7:761-65.
25. Maridonneau-Parini I, Lagente V, Lefort J, Randon J, Russo-Marie F, Vargaftig BB: Desensitization to PAF-induced broncho-constriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. Biochem Biophys Res Commun 1985, 131:42-49.
26. Ellens H, Larsen C: CD4 induced changes in gp120/40conformation and its potential relationship to fusion. In viral fusion mechanisms Edited by: BENTZ J. CRC press. Boca Raton; 1993:291-312.
27. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H: Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 1996, 274:602-5.
28. Trkola A, Dragic T, Arthos J, et al.: CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996, 384:184-87.
29. Wild TF, Malvoisin E, Buckland R: Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 1991, 72:439-42.
30. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984, 5:25-44.
31. Hansen JE, Nielsen CM, Nielsen C, Heegaard P, Mathiesen LR, Nielsen JO: Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins. AIDS 1989, 3:635-41.
32. Malvoisin E, Wild F: The role of N-glycosylation in cell fusion induced by a vaccine recombinant virus expressing both measles virus glycoproteins. Virology 1994, 200:11-20.
33. Kimpton J, Emerman M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 1992, 66:2232-39.
34. Lin P-F, Blair W, Wang T, et al.: A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding. Proc Natl acad Sci USA 2003, 100:11013-18.